18 September 2007
Circulation 2007; 116: Advance online publication
MedWire News: Vitamin E supplements significantly reduce the risk of venous thromboembolism (VTE) by up to almost 50%, results from the Women's Health Study (WHS) demonstrate.
"Given its lack of efficacy for prevention of cardiovascular disease and cancer, vitamin E may be most appropriate for people at high risk of VTE," Robert Glynn (Brigham and Women's Hospital, Boston, Massachusetts, USA) and team say.
As vitamin E is thought to inhibit vitamin K and vitamin K-dependent clotting factors, the researchers examined WHS findings to determine whether the vitamin alters the risk for VTE.
Click here to see the rest of this article in MedWire News
Reprinted with kind permission from MedWire News
0 comments:
Post a Comment